MXPA05008561A - Uso de esteroides para tratar personas que sufren de trastornos oculares. - Google Patents
Uso de esteroides para tratar personas que sufren de trastornos oculares.Info
- Publication number
- MXPA05008561A MXPA05008561A MXPA05008561A MXPA05008561A MXPA05008561A MX PA05008561 A MXPA05008561 A MX PA05008561A MX PA05008561 A MXPA05008561 A MX PA05008561A MX PA05008561 A MXPA05008561 A MX PA05008561A MX PA05008561 A MXPA05008561 A MX PA05008561A
- Authority
- MX
- Mexico
- Prior art keywords
- steroids
- ocular disorders
- treat ocular
- treat
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describen metodos y composiciones para el tratamiento de edema retinal y NPDR.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44894303P | 2003-02-20 | 2003-02-20 | |
PCT/US2004/003138 WO2004073607A2 (en) | 2003-02-20 | 2004-02-04 | Use of steroids to treat ocular disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05008561A true MXPA05008561A (es) | 2005-11-04 |
Family
ID=32908674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05008561A MXPA05008561A (es) | 2003-02-20 | 2004-02-04 | Uso de esteroides para tratar personas que sufren de trastornos oculares. |
Country Status (16)
Country | Link |
---|---|
US (2) | US20040171598A1 (es) |
EP (1) | EP1670480A4 (es) |
JP (1) | JP2006518382A (es) |
KR (1) | KR20050102652A (es) |
CN (1) | CN1750828A (es) |
AR (1) | AR043251A1 (es) |
AU (1) | AU2004212895A1 (es) |
BR (1) | BRPI0407693A (es) |
CA (1) | CA2516782A1 (es) |
MX (1) | MXPA05008561A (es) |
PL (1) | PL378210A1 (es) |
RU (1) | RU2005129276A (es) |
TW (1) | TW200511996A (es) |
UY (1) | UY28202A1 (es) |
WO (1) | WO2004073607A2 (es) |
ZA (1) | ZA200505989B (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA06003185A (es) * | 2003-09-23 | 2006-06-23 | Alcon Inc | Formulaciones de acetonuro de triamcinolona y de acetato de anecotarve para inyeccion. |
US20050101582A1 (en) * | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
ES2435398T3 (es) * | 2004-04-08 | 2013-12-19 | Eye Co Pty Ltd. | Tratamiento de retinopatía exudativa con mineralocorticoides |
BRPI0613401B8 (pt) | 2005-10-18 | 2021-05-25 | Allergan Inc | composição oftálmica compreendendo derivados de glicocorticoides que penetram seletivamente nos tecidos do segmento posterior |
US20080076742A1 (en) * | 2005-10-31 | 2008-03-27 | Wisconsin Alumni Research Foundation | Methods and compositions for treating diseases associated with neovascualrization |
ITRM20050547A1 (it) * | 2005-11-04 | 2007-05-05 | Sooft Italia S R L | Gel oftalmico composto da triamcinolone acetonide e da un polimero poliacrilico. |
AU2009223649B2 (en) | 2008-03-11 | 2013-08-29 | Novartis Ag | Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
TW201105363A (en) * | 2009-07-14 | 2011-02-16 | Univ Yamagata | Eye drop for macular edema treatment |
CA2796307A1 (en) * | 2010-05-10 | 2011-11-17 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and compositions for the treatment of fluid accumulation in and/ or under the retina |
KR101106074B1 (ko) * | 2011-05-27 | 2012-01-18 | 김선미 | 교통 시설물 설치용 부착대 및 지주장치 |
KR20170012480A (ko) | 2014-05-30 | 2017-02-02 | 오르후스 우니베르시테트 | 당뇨병을 치료하기 위한 카페스톨 |
MX2017011462A (es) | 2015-03-06 | 2018-06-19 | Envisia Therapeutics Inc | Aplicadores de implante y metodos para administrar implantes. |
WO2017015604A1 (en) * | 2015-07-23 | 2017-01-26 | Envisia Therapeutics, Inc. | Intravitreal drug delivery systems for the treatment of ocular conditions |
WO2019060696A1 (en) * | 2017-09-25 | 2019-03-28 | Surface Pharmaceuticals, Inc. | OPTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR SURFACE DISEASE |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4853224A (en) * | 1987-12-22 | 1989-08-01 | Visionex | Biodegradable ocular implants |
US5164188A (en) * | 1989-11-22 | 1992-11-17 | Visionex, Inc. | Biodegradable ocular implants |
US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
US5770592A (en) * | 1991-11-22 | 1998-06-23 | Alcon Laboratories, Inc. | Prevention and treatment of ocular neovascularization using angiostatic steroids |
US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
US6172054B1 (en) * | 1995-06-15 | 2001-01-09 | Alcon Laboratories, Inc. | Combination therapy for lowering and controlling intraocular pressure |
US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
US6011023A (en) * | 1997-08-27 | 2000-01-04 | Alcon Laboratories, Inc. | Angiostatic steroids |
US6217895B1 (en) * | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
US6416777B1 (en) * | 1999-10-21 | 2002-07-09 | Alcon Universal Ltd. | Ophthalmic drug delivery device |
PT1221917E (pt) * | 1999-10-21 | 2005-04-29 | Alcon Inc | Dispositivo para ministrar medicamentos |
DE60018777T2 (de) * | 1999-10-21 | 2006-02-02 | Alcon Inc. | Medikamentenversorgung der sub-tenon |
IL146057A (en) * | 2000-10-27 | 2007-09-20 | Pfizer Prod Inc | A process for the preparation of modulators of a non-steroidal glucocorticoid receptor |
US20030023228A1 (en) * | 2001-07-20 | 2003-01-30 | Parkinson Thomas M. | Ocular iontophoretic device and method for using the same |
-
2004
- 2004-02-04 AU AU2004212895A patent/AU2004212895A1/en not_active Abandoned
- 2004-02-04 RU RU2005129276/14A patent/RU2005129276A/ru not_active Application Discontinuation
- 2004-02-04 PL PL378210A patent/PL378210A1/pl unknown
- 2004-02-04 WO PCT/US2004/003138 patent/WO2004073607A2/en active Application Filing
- 2004-02-04 CN CNA200480004350XA patent/CN1750828A/zh active Pending
- 2004-02-04 JP JP2006503303A patent/JP2006518382A/ja active Pending
- 2004-02-04 BR BRPI0407693-1A patent/BRPI0407693A/pt not_active IP Right Cessation
- 2004-02-04 MX MXPA05008561A patent/MXPA05008561A/es not_active Application Discontinuation
- 2004-02-04 US US10/771,829 patent/US20040171598A1/en not_active Abandoned
- 2004-02-04 KR KR1020057015188A patent/KR20050102652A/ko not_active Application Discontinuation
- 2004-02-04 EP EP04708189A patent/EP1670480A4/en not_active Withdrawn
- 2004-02-04 CA CA002516782A patent/CA2516782A1/en not_active Abandoned
- 2004-02-04 ZA ZA200505989A patent/ZA200505989B/xx unknown
- 2004-02-04 US US10/545,055 patent/US20060154910A1/en not_active Abandoned
- 2004-02-19 TW TW093104084A patent/TW200511996A/zh unknown
- 2004-02-19 UY UY28202A patent/UY28202A1/es not_active Application Discontinuation
- 2004-02-20 AR ARP040100544A patent/AR043251A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR043251A1 (es) | 2005-07-20 |
PL378210A1 (pl) | 2006-03-20 |
ZA200505989B (en) | 2006-12-27 |
US20060154910A1 (en) | 2006-07-13 |
TW200511996A (en) | 2005-04-01 |
WO2004073607A3 (en) | 2004-11-25 |
AU2004212895A1 (en) | 2004-09-02 |
CA2516782A1 (en) | 2004-09-02 |
JP2006518382A (ja) | 2006-08-10 |
EP1670480A4 (en) | 2007-10-10 |
UY28202A1 (es) | 2004-08-31 |
KR20050102652A (ko) | 2005-10-26 |
US20040171598A1 (en) | 2004-09-02 |
RU2005129276A (ru) | 2006-01-27 |
CN1750828A (zh) | 2006-03-22 |
EP1670480A2 (en) | 2006-06-21 |
BRPI0407693A (pt) | 2006-03-01 |
WO2004073607A2 (en) | 2004-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200633709A (en) | Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions | |
MXPA05008561A (es) | Uso de esteroides para tratar personas que sufren de trastornos oculares. | |
HRP20090195T1 (en) | Mitotic kinesin inhibitors | |
ATE544748T1 (de) | Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen | |
TW200833341A (en) | 6-aminoimidazo[1,2-b]pyridazine analogs as rho kinase inhibitors for the treatment of rho kinase-mediated diseases and conditions | |
DE60329990D1 (de) | Mitotische kinesin-hemmer | |
IL165624A0 (en) | Mitotic kinesin inhibitors | |
GB2463833A (en) | Methods and compositions for the treatment of neurological disorders | |
EP1515949A4 (en) | INHIBITORS OF MITOTIC KINESIN | |
WO2004037171A3 (en) | Mitotic kinesin inhibitors | |
WO2005017190A3 (en) | Mitotic kinesin inhibitors | |
BRPI0506970A (pt) | derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior | |
WO2005018547A3 (en) | Mitotic kinesin inhibitors | |
MX2007004264A (es) | Uso de inhibidores de cinasas jun n-terminales para el tratamiento de retinopat??a glaucomatosa y enfermedades oculares. | |
ATE390928T1 (de) | Zusammensetzungen zur behandlung von hauterkrankungen | |
WO2001068053A3 (en) | Methods and compositions for treating and preventing posterior segment ophthalmic disorders | |
MX2007010484A (es) | Moleculas y metodos para usarlas para tratar enfermedades asociadas con mcp-1/ccr2. | |
HK1102626A1 (en) | Compositions and methods for the treatment and prevention of hyperproliferative diseases | |
ATE448779T1 (de) | Methode zur behandlung trockener augen und uveitis | |
MX2022005250A (es) | Combinaciones terapeuticas de acalabrutinib y capivasertib para tratar neoplasias malignas de linfocitos b. | |
AR043252A1 (es) | Formulaciones de glucocorticoesteroides para tratar angiogenia ocular patologica | |
EP2566856A4 (en) | COMPOUNDS AND METHODS FOR TREATING CEREBRAL DISORDERS | |
TW200603792A (en) | Monotherapy for the treatment of psoriasis with cyclooxygenase-2 selective inhibitors | |
MXPA05012696A (es) | Formulaciones de agentes antiinflamatorios no esteroides para tratar angiogenesis ocular patologica. | |
ATE482217T1 (de) | Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |